logo-loader
viewSativa Group PLC

Home Office grants Sativa Controlled Drug Licence

/**/ p{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: #000000 }visited{ color: fuchsia } .bc{size:595.0pt 842.0pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.bc{}p.r,li.r,div.r{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;border:none;}span.ck{font-size:11.0pt;font-family:"Calibri","sans-serif"}table.cm{margin-left:-5.4pt;border-collapse:collapse}td.ce{width:214.45pt;padding:0cm 5.4pt 0cm 5.4pt}p.cn{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;border:none;border: none; font-div: italic}span.ci{border: none; font-family: "Calibri","sans-serif"; font-size: 11.0pt}span.cj{border:none}p.co{margin-top:6.0pt;margin-right:0cm;margin-bottom:2.0pt;margin-left:0cm;text-align:justify;text-justify:inter-ideograph;font-size:10.0pt;font-family:"Times New Roman","serif";font-div: italic; font-weight: bold; margin: 0cm; margin-bottom: .0001pt; text-align: left} span.cg{font-family:"Calibri","sans-serif"}p.cp{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;border:none;border: none; font-div: italic; text-align: right}p.cq{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;border:none;font-weight: bold; text-align: center}p.cr{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";border:none;border: none; font-weight: bold; text-align: center}span.ca{font-family:"Calibri","sans-serif";border:none}p.cs{margin-top:6.0pt;margin-right:0cm;margin-bottom:2.0pt;margin-left:0cm;text-align:justify;text-justify:inter-ideograph;font-size:10.0pt;font-family:"Times New Roman","serif";font-weight: bold; margin: 0cm; margin-bottom: .0001pt; text-align: center}span.by{font-size:12.0pt;font-family: "Calibri","sans-serif"}p.ct{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;border:none;text-align:justify;text-justify:inter-ideograph}span.bv{font-family:"Calibri","sans-serif";color:windowtext;border:none}span.bu{border: none; color: windowtext; font-family: "Calibri","sans-serif"} p.cu{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;border:none;font-weight: bold; line-height: 107%; margin-bottom: 8.0pt; text-align: center}p.a,li.a,div.a{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";border:none;}span.bs{font-family:"Calibri","sans-serif";color:black}p.cv{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;border:none;margin-bottom:8.0pt;line-height:107%}table.cw{margin-left:6.8pt;border-collapse:collapse;border:none}tr.bl{height:61.0pt}td.bo{width:204.55pt;border:none;padding:4.0pt 17.55pt 4.0pt 4.0pt; height:61.0pt}p.cx{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;border:none;margin-right:13.55pt;text-align:justify;text-justify: inter-ideograph}span.bp{font-family:"Calibri","sans-serif"; color:#070036;background:white}span.v{font-family:"Calibri","sans-serif";color:blue;text-decoration:underline;} td.bm{width:205.2pt;border:none;padding:4.0pt 16.95pt 4.0pt 4.0pt; height:61.0pt}p.cy{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;border:none;margin-right:12.95pt;text-align:justify;text-justify: inter-ideograph}span.cz{font-family:"Calibri","sans-serif"}span.da{font-family:"Calibri","sans-serif"; color:#070036;background:white}tr.bg{height:73.0pt}td.bi{width:204.55pt;border:none;padding:4.0pt 17.55pt 4.0pt 4.0pt; height:73.0pt}span.db{font-family: "Calibri","sans-serif"; font-weight: bold}p.dc{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";color:black;border:none;font-weight: bold; margin-right: 13.55pt; text-align: justify; text-justify: inter-ideograph}td.bh{width:205.2pt;border:none;padding:4.0pt 16.95pt 4.0pt 4.0pt; height:73.0pt}td.bf{width:218.15pt;border:none;padding:4.0pt 4.0pt 4.0pt 4.0pt; height:73.0pt} span.dd{font-family:"Calibri","sans-serif"}p.de{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";border: none; line-height: 150%; margin-bottom: 0cm; margin-left: 21.0pt; margin-right: 0cm; margin-top: 0cm; text-align: center; text-indent: -18.0pt; vertical-align: baseline} /**/
RNS Number : 0415Q
Sativa Group PLC
16 October 2019
 

 

16 October 2019

 

Press release

Sativa Group Plc

 

 ("Sativa" or "the Group" or "the Company")

 

Home Office Grants Sativa a Controlled Drug Licence 

 

Sativa Group Plc (NEX: SATI), the UK's leading quoted CBD wellness and medicinal cannabis Group, is pleased to announce that its wholly owned subsidiary, Sativa Cultivation and Extraction Ltd, has been awarded a Controlled Drug licence for cannabis (with THC content of greater than 0.2%) cultivation, production, possession and supply, at its Somerset headquarters, by the UK Home Office.  The Group is therefore able to commence immediately the fulfilment of its research partnership agreement with King's College London ("the College") to research the impact of cannabinoids on inflammation and respiratory conditions. 

 

The cannabis plants will be grown from seeds sourced from an EU approved supplier and are estimated to have a growing cycle of 12 weeks, allowing for multiple crops per year.  The Group already has a purpose-built secure growing facility that has been inspected by the Home Office as part of the application process.  Once they have reached maturity, the plants will be dried, and the cannabinoids then extracted as a liquid using pressure and heat. 

 

The process is strictly controlled to standard operating procedures approved by the UK Home Office, including all handling, transportation to the College, and the disposal of residual waste and by-products. 

 

Dr Nick Horniman, Sativa's Director of Regulatory Affairs, said:  "This high-THC cultivation license complements our low-THC Industrial Hemp licence, held in the name of Geremy Thomas, Founder and Deputy Chairman of Sativa, that was granted in April 2018, and we continue to work with the regulators to broaden the suite of licences as the Group expands its operations." 

 

Henry Lees-Buckley, Chief Executive Officer of Sativa, said:  "We are delighted to receive this licence, responding to calls from regulators, government and healthcare providers for further research and development into the efficacy of medicinal cannabis.  We are committed to operating at these high standards and to partner with Kings College London, to help establish a clinical pathway for patients to access medicinal cannabis." 

 

  Ends  -

 

 

For further information please contact:

 

Henry Lees-Buckley 

Chief Executive Officer

Sativa Group Plc

+44 (0) 20 7971 1255

[email protected]

www.sativagroup.co.uk

 

Joseph Colliver

Chief Financial Officer

Sativa Group Plc

+44 (0) 20 7971 1255

[email protected]

www.sativagroup.co.uk

 

 

NEX Exchange Corporate Adviser

 

Corporate Finance 

 

Stephen Keys / Max Gould 

Cenkos Securities plc 

+44 (0) 20 7397 8900

 

Equity Sales 

 

Julian Morse

Cenkos Securities

+44 (0) 20 7397 8900

 


Financial PR and IR

 

Abchurch Communications

Julian Bosdet

+44 (0) 20 7459 4070 

+44 (0) 7771 663 886

 

[email protected]

 

 

 

 

 

 

 

-     Ends -


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NEXGUBDGDUBBGCL

Quick facts: Sativa Group PLC

Price: 5.75

Market: NEX
Market Cap: -
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Sativa Group is setting up for the future after Home Office...

Sativa Group (LON: SATI) CEO Henry Lees-Buckley joined Steve Darling from Proactive Vancouver to discuss the UK’s first listed Cannabis Company. This company focussing on 4 key business areas. Lee-Buckley talking about those areas and why he feels the UK is the right place at the right time...

2 weeks, 1 day ago